Category: Pasadena

Eli Lilly gets glucose-sensing “smart insulin” via buyout of preclinical Protomer

Acquisitions, Alborz Mahdavi, BioPharma, California, Daily, deals, diabetes, Eli Lilly, Indianapolis, Pasadena, Pharma, Protomer Technologies, SYN, Top Story / July 14, 2021 July 14, 2021

Eli Lilly has Protomer Technologies, a preclinical startup developing next-generation insulin that senses blood glucose levels and adjusts its activity accordingly. The technology could eliminate the need for multiple insulin injections throughout the day.

Founder of at-home primary care startup Heal steps down

Daily, Heal, Health Services, home health, Humana, Nick Desai, Pasadena, startup, Startups, SYN, Top Story / March 10, 2021 March 10, 2021

Nick Desai, the co-founder and CEO of Heal, announced he would step down on Tuesday. Scott Vertrees, an advisor to the company, will become the company’s new CEO.

Takeda strikes $1B RNAi deal with Arrowhead Pharmaceuticals

AATLD, alpha-1 antitrypsin-associated liver disease, ARO-AAT, Arrowhead Pharmaceuticals, BioPharma, biopharma nl, Californai, Daily, Japan, Osaka, Pasadena, SYN, Takeda Pharmaceutical Company, Top Story / October 8, 2020 October 8, 2020

The companies will partner on development and commercialization of ARO-AAT, Arrowhead’s Phase II RNA-interference drug for alpha-1 antitrypsin-associated liver disease, a rare genetic disorder. An analyst wrote that the deal makes sense given Takeda’s position in the AAT-augmentation therapy market.

Kaiser Permanente opens new medical school in Pasadena

Daily, hospitals, Kasier Permanente, Los Angeles, medical school, Pasadena, Payers, SYN, Top Story / July 28, 2020 July 28, 2020

Kaiser Permanente opened its first medical school in Pasadena, California. Its first class of 50 students will have a mixture of in-person and virtual classes this year.